Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
5 studies found for:    10102814 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  CD133+ Cell Therapy for Refractory Coronary Heart Disease
Condition: Coronary Artery Disease
Intervention: Procedure: Intracoronary Infusion of CD133+ Cells
2 Not yet recruiting Injections of FloGraft Therapy, Autologous Stem Cells, or Platelet Rich Plasma for the Treatment of Degenerative Joint Pain
Conditions: Osteoarthritis;   Rheumatoid Arthritis
Intervention:
3 Recruiting Bone Marrow Stromal Cells for Inflammatory Bowel Diseases
Condition: Inflammatory Bowel Disease
Intervention: Other: Bone Marrow Stromal Cell (BMSC) Infusion
4 Completed A Phase I/II Study of Chondrogen Delivered by Intra-Articular Injection Following Meniscectomy
Condition: Recovery Following Partial Medial Meniscectomy
Intervention: Drug: Mesenchymal Stem Cells
5 Unknown  Mensenchymal Stem Cell (MSC) Included in OrthADAPT Membrane for Rotator Cuff Tears Repair
Condition: Chronic Disease
Interventions: Biological: Mesenchymal Stem Cells (MSCs);   Biological: OrthADAPT

Indicates status has not been verified in more than two years